GB0706537D0 - Transcutaneous cancer therapeutic - Google Patents
Transcutaneous cancer therapeuticInfo
- Publication number
- GB0706537D0 GB0706537D0 GB0706537A GB0706537A GB0706537D0 GB 0706537 D0 GB0706537 D0 GB 0706537D0 GB 0706537 A GB0706537 A GB 0706537A GB 0706537 A GB0706537 A GB 0706537A GB 0706537 D0 GB0706537 D0 GB 0706537D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- cancer therapeutic
- transcutaneous
- transcutaneous cancer
- therapeutic
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0706537A GB0706537D0 (en) | 2007-04-04 | 2007-04-04 | Transcutaneous cancer therapeutic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0706537A GB0706537D0 (en) | 2007-04-04 | 2007-04-04 | Transcutaneous cancer therapeutic |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0706537D0 true GB0706537D0 (en) | 2007-05-09 |
Family
ID=38050807
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0706537A Ceased GB0706537D0 (en) | 2007-04-04 | 2007-04-04 | Transcutaneous cancer therapeutic |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB0706537D0 (en) |
-
2007
- 2007-04-04 GB GB0706537A patent/GB0706537D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201004403B (en) | Therapeutic cancer treatments | |
HRP20181385T1 (en) | Targeting abcb5 for cancer therapy | |
EP2127671A4 (en) | Therapeutic agent for cancer | |
IL199992A0 (en) | Combination therapy | |
GB0719518D0 (en) | Therapy | |
HK1142774A1 (en) | Therapeutic pyrazolonaphthyridine derivatives | |
EP2211863A4 (en) | Combination therapy | |
GB0700284D0 (en) | Combination therapy | |
EP2473613A4 (en) | Cancer starvation therapy | |
GB0707556D0 (en) | Treatment for cancer | |
EP2099303A4 (en) | Therapeutic tetrahydroisoquinoline-based compositions for cancer therapy | |
GB0809046D0 (en) | Cancer treatment | |
GB0808690D0 (en) | Therapeutic use | |
GB0706537D0 (en) | Transcutaneous cancer therapeutic | |
GB0716072D0 (en) | Therapy | |
GB0700635D0 (en) | Therapy | |
PT2305654E (en) | Therapeutic agent for cancer pain | |
GB0606703D0 (en) | Transcutaneous cancer therapeutic | |
GB0612258D0 (en) | Transcutaneous cancer therapeutic | |
GB0706538D0 (en) | Cancer therapeutic | |
GB0710871D0 (en) | Cancer treatment | |
GB0606702D0 (en) | Cancer therapeutic | |
GB0612259D0 (en) | Cancer therapeutic | |
GB0723503D0 (en) | Cancer treatment | |
GB0700493D0 (en) | Cancer treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |